Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy-Reference-Cited by-同舟云学术

Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy

Published:2007-07 Issue:1 Volume:12 Page:81-93
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Li Danan,Shimamura Takeshi,Ji Hongbin,Chen Liang,Haringsma Henry J.,McNamara Kate,Liang Mei-Chih,Perera Samanthi A.,Zaghlul Sara,Borgman Christa L.,Kubo Shigeto,Takahashi Masaya,Sun Yanping,Chirieac Lucian R.,Padera Robert F.,Lindeman Neal I.,Jänne Pasi A.,Thomas Roman K.,Meyerson Matthew L.,Eck Michael J.,Engelman Jeffrey A.,Shapiro Geoffrey I.,Wong Kwok-Kin

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference33 articles.

1. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR;Bell;Nat. Genet.,2005

2. Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors;Buck;Mol. Cancer Ther.,2006

3. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer;Cappuzzo;J. Natl. Cancer Inst.,2005

4. Molecular context of the EGFR mutations: Evidence for the activation of mTOR/S6K signaling;Conde;Clin. Cancer Res.,2006

5. IRS-1: Auditing the effectiveness of mTOR inhibitors;Easton;Cancer Cell,2006

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development;Cancer Treatment Reviews;2024-09

2. Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer;Cell Death & Disease;2024-08-09

3. Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment;Cancer Research Communications;2024-03-26

4. Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids;Methods in Molecular Biology;2024

5. The Role and Future Development of EGFR Allosteric Inhibitors in the Treatment of Small Cell Lung Cancer;Hans Journal of Medicinal Chemistry;2024